Cancer Research Center Hotline: Induction of Breast Cancer in Wild Type p53 Cells by BRCA1-IRIS Overexpression

Por ElShamy, Wael M
Publicado em 2010

The role of BRCA1-IRIS in ovarian cancer formation, drug resistance and progression

Por ElShamy, Wael M.
Publicado no Oncoscience (2016)

Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors?

Por ElShamy, Wael M., Sinha, Abhilasha, Said, Neveen
Publicado no Stem Cells Int (2016)

BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells

Por Shimizu, Yoshiko, Mullins, Nicole, Blanchard, Zannel, ElShamy, Wael M.
Publicado em 2012

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers

Por Blanchard, Zannel, Paul, Bibbin T, Craft, Barbara, ElShamy, Wael M
Publicado no Breast Cancer Res (2015)

Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells

Por Gardner, Lauren, Malik, Rohit, Shimizu, Yoshiko, Mullins, Nicole, ElShamy, Wael M
Publicado em 2011

A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment

Por Ryan, Daniel, Bogan, Danielle, Davies, Joanna, Koziol, Jim, ElShamy, Wael M.
Publicado no Oncotarget (2017)

Correction: A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment

Por Ryan, Daniel, Sinha, Abhilasha, Bogan, Danielle, Davies, Joanna, Koziol, Jim, ElShamy, Wael M.
Publicado no Oncotarget (2017)

BRCA1-IRIS Overexpression Promotes Formation of Aggressive Breast Cancers

Por Shimizu, Yoshiko, Luk, Hugh, Horio, David, Miron, Penelope, Griswold, Michael, Iglehart, Dirk, Hernandez, Brenda, Killeen, Jeffrey, ElShamy, Wael M.
Publicado em 2012

Geminin overexpression induces mammary tumors via suppressing cytokinesis

Por Blanchard, Zannel, Malik, Rohit, Mullins, Nicole, Maric, Christine, Luk, Hugh, Horio, David, Hernandez, Brenda, Killeen, Jeffrey, ElShamy, Wael M.
Publicado em 2011

Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers

Por Ananthula, Suryatheja, Sinha, Abhilasha, Gassim, Mohamed El, Batth, Simran, Marshall, Gailen D., Gardner, Lauren H., Shimizu, Yoshiko, ElShamy, Wael M.
Publicado no Oncotarget (2016)

The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion

Por Bogan, Danielle, Meile, Lucio, El Bastawisy, Ahmed, Yousef, Hend F., Zekri, Abdel-Rahman N., Bahnassy, Abeer A., ElShamy, Wael M.
Publicado no BMC Cancer (2017)

Geminin Overexpression Promotes Imatinib Sensitive Breast Cancer: A Novel Treatment Approach for Aggressive Breast Cancers, Including a Subset of Triple Negative

Por Blanchard, Zannel, Mullins, Nicole, Ellipeddi, Pavani, Lage, Janice M., McKinney, Shawn, El-Etriby, Rana, Zhang, Xu, Isokpehi, Raphael, Hernandez, Brenda, ElShamy, Wael M.
Publicado em 2014

BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions

Por Sinha, Abhilasha, Paul, Bibbin T., Sullivan, Lisa M., Sims, Hillary, Bastawisy, Ahmed El, Yousef, Hend F., Zekri, Abdel-Rahman N., Bahnassy, Abeer A., ElShamy, Wael M.
Publicado no Oncotarget (2016)